Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)
National Institutes of Health · Department of Health and Human Services
At a glance
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) is an open federal cooperative agreement opportunity from the National Institutes of Health (Department of Health and Human Services). Applications are due November 23, 2026. Total estimated funding is $6M across about 15 awards. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 10 more. Cost sharing is not required. It is funded under Assistance Listing 93.310 (Trans-NIH Research Support).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Oct 9, 2026Postednext date
- Nov 23, 2026Application deadline
- Jul 1, 2026 (est.)Est. award date
- Jan 22, 2027Archived
- Posted
- Oct 9, 2026
- Close date
- Nov 23, 2026
- Archive date
- Jan 22, 2027
- Est. award date
- Jul 1, 2026
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- $6,000,000
- Implied average award
- $400,000 calculated
- Expected awards
- 15
- Cost sharing
- Not required
- Funding instrument
- Cooperative Agreement
- Opportunity category
- Discretionary
Typical awards for this program (SAM.gov listing for ALN 93.310, not this notice): $3,000 to $27,999,994 with the average being $640,952.
Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Nonprofits without 501(c)(3) status
- Private colleges & universities
- For-profit organizations (not small businesses)
- Small businesses
- Others (see notice)
Additional information on eligibility (from the notice)
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit the development of innovative senescence technologies (SenTecs), or the adaptation of existing technologies focused on identification, characterization and understanding the biological consequences of senescent cell (SnC) heterogeneity in the context of the tissue environments and secretomes to facilitate novel strategies for modulating SnCs in vivo and for predicting the outcomes of targeting SnCs in human aging and in disease conditions. These are five-year, milestone-driven awards consisting of two phases. The first two years constitute the UG3 phase and are focused on SenTec development and demonstration of technology feasibility. The following 3-years is the SenTec application UH3 phase where SenTecs continue to be optimized, refined and validated. In the final year of the UH3 award, SenTecs will undertake a demonstration project conducted in a collaborative effort within SenNet to provide further validation of the proposed SenTec. Applicants are required to submit both UG3 and UH3 projects together when responding to this NOFO. Transition from the UG3 to UH3 phases is not automatic and will occur only after administrative review of each SenTec at the close of Year 2 of the award.
Full announcement & documents
The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.
How to apply
0 of 8 done · progress saved in this browser
Assistance Listing
What is an ALN?Reported obligations under ALN 93.310
Historical data · not a predictionWho was funded under ALN 93.310
Historical data · not a predictionSince October 1, 2023, 5,175 grant awards had funding actions under Trans-NIH Research Support, with 7,955 sub-awards passed on to other organizations. These are program-wide awards, not awards from this specific notice.
- WASHINGTON UNIVERSITY, THE$96.5M
- THE CHILDREN'S HOSPITAL OF PHILADELPHIA$95.5M
- THE LELAND STANFORD JUNIOR UNIVERSITY$95.3M
- YALE UNIV$81.2M
- THE JOHNS HOPKINS UNIVERSITY$76M
Agency contact (as published)
National Institutes of Health
CS2@nih.gov
301-402-2541
Changes we detected
- Oct 9, 2026: Contact email changed from ajay.pillai3@nih.gov to CS2@nih.gov
- Oct 9, 2026: Title changed
- Oct 9, 2026: Close date changed
Quick answers
When is the deadline for this opportunity?
According to the official notice, applications are due November 23, 2026. Confirm the deadline and submission time on Grants.gov before applying.
Who is eligible to apply for this opportunity?
The official notice names these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 3 more. Additional restrictions may apply; review the full notice.
How much funding is available through this opportunity?
Per the notice, total estimated program funding is $6,000,000 and the agency expects to make about 15 awards.
How do I apply for this opportunity?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity RFA-RM-27-007), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Nov 13, 2025 (est.)
- Who can apply
- State governments, County governments, Independent school districts and 8 more
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Oct 1, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Oct 19, 2026
- Who can apply
- State governments, County governments, City or township governments and 12 more
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Oct 19, 2026
- Who can apply
- State governments, County governments, City or township governments and 12 more
HIV/AIDS Clinical Trials Network Clinical Trials Units
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jan 22, 2027 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)
National Institutes of Health- Award range
- Amount not specified
- Closes
- May 7, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more